David McCullough, VP at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 574 shares at $4.78 ($3K) on 2012-03-02, disclosed to the SEC on 2012-03-05.
Open-market sale of $3k BCRX by VP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2010-01-25 | $100K | — | Filing → |